Sunstone Capital
Sunstone Capital
Sunstone Life Science Ventures is an independent European venture capital investment firm.
- Use: Go2Market;
- Date closing: -
- Amount: -
- Industry focus: Health;
- Total budget: 92M €
- Entity type: Venture Capital
- Vertical focus: therapeutics, health,
- Website: www.sunstone.eu
- Status: Open
- Funding type: Equity investment;
- Geographic focus: Europe; Nordics;
- Public/Private: Private
- Stage focus: Seed; Series A;
- Applicant target: Startup;
Overview
Sunstone Life Science Ventures invests in early-stage life science companies developing novel therapeutics for humans. They are a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use
Their portfolio is managed through a series of funds. Fund IV, focusing solely on therapeutics, is actively pursuing new investment opportunities.
Their geographical scope is Europe including UK with particular emphasis on the European life science hubs.
Sunstone Life Science Ventures Fund IV was established in 2019. The total committed capital is EUR 92 million. The investment strategy is focused entirely on therapeutics. The fund is currently building the portfolio and is actively pursuing new investment opportunities.
Sunstone Capital FAQ
Sunstone Capital Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Sunstone Capital News
Featured Funds
- Usage: R&D; Go2Market;
- Entity type: Public Agency
- Funding type: Grant;
- Geographic focus: Sweden;
- 0 reviews 0 questions
- Usage: Go2Market;
- Entity type: Accelerator
- Funding type: Crowdfunding; Equity investment; In kind; Other;
- Status: Open
- 0 reviews 0 questions
- Usage: R&D; Go2Market; Social & Environment; Other;
- Entity type: Public Agency
- Total: 8B €
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Spain;
- 0 reviews 1 questions